Brief: Sientra Announces Acquisition Of OPUS Breast Implant Manufacturing Operation From Lubrizol Life Science
07/11/2019 23:47
Nov 7 (Reuters) - Sientra Inc SIEN.O :
* SIENTRA ANNOUNCES ACQUISITION OF THE INDEPENDENTLY
OPERATED
OPUS® BREAST IMPLANT MANUFACTURING OPERATION FROM LUBRIZOL LIFE
SCIENCE
* SIENTRA INC - TOTAL TRANSACTION CONSIDERATION OF $20
MILLION IN
CASH AND UP TO 607,442 SHARES OF SIENTRA STOCK
* SIENTRA - AGREED TO A TRANSITION SERVICES AGREEMENT AND A
LONG-TERM LEASE AGREEMENT OF EXISTING AND EXPANSION SPACE IN
LUBRIZOL'S FRANKLIN FACILITY
Source text for Eikon: ID:nGNX3GWYjp
Further company coverage: SIEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Project Sage Oldco
See all newsBrief: Sientra Says Bankruptcy Court Entered An Order Approving Dip Credit Agreement On An Interim Basis On Feb 14
Brief: Sientra To Pursue Strategic Sale Of Its Business Through Voluntary Chapter 11 Process
U.S. STOCKS ON THE MOVE-premarket
Brief: Sientra Files For Voluntary Chapter 11 Bankruptcy In The U.S. - Court Filing
Brief: Sientra Says Co Entered Into Amendment No. 2 To Temporary Waiver And Exchange Agreement And Temporary Amendment To Facility Agreement